APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxytocin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oxytocin Injection Industry Growth and Trends Forecast to 2032

22 December 2025101 pages

Choose your research edition.

Industry ResearchOxytocin Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxytocin Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oxytocin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxytocin Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxytocin Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Oxytocin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oxytocin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oxytocin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxytocin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oxytocin Injection include Shanghai Hefeng, Novartis, Renjian Pharmaceutical, Pfizer, Hybio Pharmaceutical, GSK, Bayer, Kepro B.V. and JHP Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oxytocin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oxytocin Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oxytocin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oxytocin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oxytocin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oxytocin Injection Market by Company

Shanghai Hefeng

Novartis

Renjian Pharmaceutical

Pfizer

Hybio Pharmaceutical

GSK

Bayer

Kepro B.V.

JHP Pharmaceuticals

Grindex

Bimeda

Agrilab

Oxytocin Injection Segment by Type

Oxytocin

Carbetocin

Oxytocin Injection Segment by Application

Animal Use

Human Use

Oxytocin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxytocin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxytocin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxytocin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oxytocin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oxytocin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oxytocin Table 2. Major Company of Carbetocin Table 3. Global Oxytocin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oxytocin Injection Sales by Type (2021-2026) & (k units) Table 5. Global Oxytocin Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oxytocin Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oxytocin Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Oxytocin Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Oxytocin Injection Sales by Type (2027-2032) & (k units) Table 10. Global Oxytocin Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oxytocin Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oxytocin Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Oxytocin Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Oxytocin Injection Sales by Type (2021-2026) & (k units) Table 15. North America Oxytocin Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oxytocin Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Oxytocin Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oxytocin Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Oxytocin Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oxytocin Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Oxytocin Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oxytocin Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Oxytocin Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Oxytocin Injection Industry Trends Table 25. Oxytocin Injection Industry Drivers Table 26. Oxytocin Injection Industry Opportunities and Challenges Table 27. Oxytocin Injection Industry Restraints Table 28. Global Oxytocin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oxytocin Injection Revenue Market Share by Company (2021-2026) Table 30. Global Oxytocin Injection Sales by Company (2021-2026) & (k units) Table 31. Global Oxytocin Injection Sales Share by Company (2021-2026) Table 32. Global Oxytocin Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Oxytocin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oxytocin Injection Major Company Production Sites and Headquarters Table 35. Global Oxytocin Injection Company, Product Type & Application Table 36. Global Oxytocin Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oxytocin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oxytocin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oxytocin Injection Sales by Region (2021-2026) & (k units) Table 41. Global Oxytocin Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oxytocin Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oxytocin Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Oxytocin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Oxytocin Injection Sales by Region (2027-2032) & (k units) Table 46. Global Oxytocin Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oxytocin Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oxytocin Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Oxytocin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Oxytocin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oxytocin Injection Sales by Application (2021-2026) & (k units) Table 52. Global Oxytocin Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oxytocin Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oxytocin Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Oxytocin Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Oxytocin Injection Sales by Application (2027-2032) & (k units) Table 57. Global Oxytocin Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oxytocin Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oxytocin Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Oxytocin Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Oxytocin Injection Sales by Application (2021-2026) & (k units) Table 62. North America Oxytocin Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oxytocin Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Oxytocin Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oxytocin Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Oxytocin Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oxytocin Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Oxytocin Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oxytocin Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Oxytocin Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Shanghai Hefeng Company Information Table 72. Shanghai Hefeng Business Overview Table 73. Shanghai Hefeng Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Shanghai Hefeng Oxytocin Injection Product Portfolio Table 75. Shanghai Hefeng Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis Oxytocin Injection Product Portfolio Table 80. Novartis Recent Development Table 81. Renjian Pharmaceutical Company Information Table 82. Renjian Pharmaceutical Business Overview Table 83. Renjian Pharmaceutical Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Renjian Pharmaceutical Oxytocin Injection Product Portfolio Table 85. Renjian Pharmaceutical Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Oxytocin Injection Product Portfolio Table 90. Pfizer Recent Development Table 91. Hybio Pharmaceutical Company Information Table 92. Hybio Pharmaceutical Business Overview Table 93. Hybio Pharmaceutical Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Hybio Pharmaceutical Oxytocin Injection Product Portfolio Table 95. Hybio Pharmaceutical Recent Development Table 96. GSK Company Information Table 97. GSK Business Overview Table 98. GSK Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. GSK Oxytocin Injection Product Portfolio Table 100. GSK Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Bayer Oxytocin Injection Product Portfolio Table 105. Bayer Recent Development Table 106. Kepro B.V. Company Information Table 107. Kepro B.V. Business Overview Table 108. Kepro B.V. Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Kepro B.V. Oxytocin Injection Product Portfolio Table 110. Kepro B.V. Recent Development Table 111. JHP Pharmaceuticals Company Information Table 112. JHP Pharmaceuticals Business Overview Table 113. JHP Pharmaceuticals Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. JHP Pharmaceuticals Oxytocin Injection Product Portfolio Table 115. JHP Pharmaceuticals Recent Development Table 116. Grindex Company Information Table 117. Grindex Business Overview Table 118. Grindex Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Grindex Oxytocin Injection Product Portfolio Table 120. Grindex Recent Development Table 121. Bimeda Company Information Table 122. Bimeda Business Overview Table 123. Bimeda Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Bimeda Oxytocin Injection Product Portfolio Table 125. Bimeda Recent Development Table 126. Agrilab Company Information Table 127. Agrilab Business Overview Table 128. Agrilab Oxytocin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Agrilab Oxytocin Injection Product Portfolio Table 130. Agrilab Recent Development Table 131. North America Oxytocin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. North America Oxytocin Injection Sales by Country (2021-2026) & (k units) Table 133. North America Oxytocin Injection Sales Market Share by Country (2021-2026) Table 134. North America Oxytocin Injection Sales Forecast by Country (2027-2032) & (k units) Table 135. North America Oxytocin Injection Sales Market Share Forecast by Country (2027-2032) Table 136. North America Oxytocin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Oxytocin Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Oxytocin Injection Market Share by Country (2021-2026) Table 139. North America Oxytocin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Oxytocin Injection Market Share Forecast by Country (2027-2032) Table 141. Europe Oxytocin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Europe Oxytocin Injection Sales by Country (2021-2026) & (k units) Table 143. Europe Oxytocin Injection Sales Market Share by Country (2021-2026) Table 144. Europe Oxytocin Injection Sales Forecast by Country (2027-2032) & (k units) Table 145. Europe Oxytocin Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Oxytocin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Oxytocin Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Oxytocin Injection Market Share by Country (2021-2026) Table 149. Europe Oxytocin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Oxytocin Injection Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Oxytocin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Oxytocin Injection Sales by Country (2021-2026) & (k units) Table 153. Asia-Pacific Oxytocin Injection Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Oxytocin Injection Sales Forecast by Country (2027-2032) & (k units) Table 155. Asia-Pacific Oxytocin Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Oxytocin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Oxytocin Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Oxytocin Injection Market Share by Country (2021-2026) Table 159. Asia-Pacific Oxytocin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Oxytocin Injection Market Share Forecast by Country (2027-2032) Table 161. Latin America Oxytocin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Latin America Oxytocin Injection Sales by Country (2021-2026) & (k units) Table 163. Latin America Oxytocin Injection Sales Market Share by Country (2021-2026) Table 164. Latin America Oxytocin Injection Sales Forecast by Country (2027-2032) & (k units) Table 165. Latin America Oxytocin Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Oxytocin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Oxytocin Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Oxytocin Injection Market Share by Country (2021-2026) Table 169. Latin America Oxytocin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Oxytocin Injection Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Oxytocin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Oxytocin Injection Sales by Country (2021-2026) & (k units) Table 173. Middle East and Africa Oxytocin Injection Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Oxytocin Injection Sales Forecast by Country (2027-2032) & (k units) Table 175. Middle East and Africa Oxytocin Injection Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Oxytocin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Oxytocin Injection Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Oxytocin Injection Market Share by Country (2021-2026) Table 179. Middle East and Africa Oxytocin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Oxytocin Injection Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Oxytocin Injection Distributors List Table 184. Oxytocin Injection Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Oxytocin Injection Image Figure 2. Global Oxytocin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxytocin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Oxytocin Injection Sales (2021-2032) & (k units) Figure 5. Oxytocin Image Figure 6. Global Oxytocin Sales YoY Growth (2021-2032) & (k units) Figure 7. Carbetocin Image Figure 8. Global Carbetocin Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Oxytocin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oxytocin Injection Market Share by Type 2025 VS 2032 Figure 11. North America Oxytocin Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Oxytocin Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Oxytocin Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oxytocin Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oxytocin Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oxytocin Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oxytocin Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oxytocin Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oxytocin Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oxytocin Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oxytocin Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Animal Use Image Figure 24. Global Animal Use Sales YoY Growth (2021-2032) & (k units) Figure 25. Human Use Image Figure 26. Global Human Use Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Oxytocin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Oxytocin Injection Market Share by Application 2025 VS 2032 Figure 29. North America Oxytocin Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Oxytocin Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Oxytocin Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Oxytocin Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Oxytocin Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Oxytocin Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Oxytocin Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Oxytocin Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Oxytocin Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Oxytocin Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Oxytocin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Oxytocin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Oxytocin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Oxytocin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Oxytocin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Oxytocin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Oxytocin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Oxytocin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Oxytocin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Oxytocin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Oxytocin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Oxytocin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Oxytocin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Oxytocin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oxytocin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Oxytocin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Oxytocin Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Oxytocin Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oxytocin
  • Carbetocin
Applications
  • Animal Use
  • Human Use
Companies covered
  • Shanghai Hefeng
  • Novartis
  • Renjian Pharmaceutical
  • Pfizer
  • Hybio Pharmaceutical
  • GSK
  • Bayer
  • Kepro B.V.
  • JHP Pharmaceuticals
  • Grindex
  • Bimeda
  • Agrilab

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oxytocin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oxytocin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oxytocin Injection Market by Type
  6. 1.3.1 Oxytocin
  7. 1.3.2 Carbetocin
  8. 1.4 Global Oxytocin Injection Market Size by Type
  9. 1.4.1 Global Oxytocin Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oxytocin Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oxytocin Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oxytocin Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oxytocin Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oxytocin Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oxytocin Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oxytocin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oxytocin Injection Industry Trends
  2. 2.2 Oxytocin Injection Industry Drivers
  3. 2.3 Oxytocin Injection Industry Opportunities and Challenges
  4. 2.4 Oxytocin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oxytocin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Oxytocin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Oxytocin Injection Price (2021-2026)
  4. 3.4 Global Oxytocin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oxytocin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Oxytocin Injection Company, Product Type & Application
  7. 3.7 Global Oxytocin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oxytocin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oxytocin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oxytocin Injection Tier 1, Tier 2, and Tier 3
4 Oxytocin Injection Regional Status and Outlook
  1. 4.1 Global Oxytocin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oxytocin Injection Historic Market Size by Region
  3. 4.2.1 Global Oxytocin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oxytocin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oxytocin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oxytocin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Oxytocin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oxytocin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oxytocin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oxytocin Injection by Application
  1. 5.1 Oxytocin Injection Market by Application
  2. 5.1.1 Animal Use
  3. 5.1.2 Human Use
  4. 5.2 Global Oxytocin Injection Market Size by Application
  5. 5.2.1 Global Oxytocin Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oxytocin Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oxytocin Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oxytocin Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oxytocin Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oxytocin Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oxytocin Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oxytocin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Hefeng
  2. 6.1.1 Shanghai Hefeng Company Information
  3. 6.1.2 Shanghai Hefeng Business Overview
  4. 6.1.3 Shanghai Hefeng Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Hefeng Oxytocin Injection Product Portfolio
  6. 6.1.5 Shanghai Hefeng Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Oxytocin Injection Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Renjian Pharmaceutical
  14. 6.3.1 Renjian Pharmaceutical Company Information
  15. 6.3.2 Renjian Pharmaceutical Business Overview
  16. 6.3.3 Renjian Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Renjian Pharmaceutical Oxytocin Injection Product Portfolio
  18. 6.3.5 Renjian Pharmaceutical Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Oxytocin Injection Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Hybio Pharmaceutical
  26. 6.5.1 Hybio Pharmaceutical Company Information
  27. 6.5.2 Hybio Pharmaceutical Business Overview
  28. 6.5.3 Hybio Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hybio Pharmaceutical Oxytocin Injection Product Portfolio
  30. 6.5.5 Hybio Pharmaceutical Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Oxytocin Injection Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Oxytocin Injection Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 Kepro B.V.
  44. 6.8.1 Kepro B.V. Company Information
  45. 6.8.2 Kepro B.V. Business Overview
  46. 6.8.3 Kepro B.V. Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kepro B.V. Oxytocin Injection Product Portfolio
  48. 6.8.5 Kepro B.V. Recent Developments
  49. 6.9 JHP Pharmaceuticals
  50. 6.9.1 JHP Pharmaceuticals Company Information
  51. 6.9.2 JHP Pharmaceuticals Business Overview
  52. 6.9.3 JHP Pharmaceuticals Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 JHP Pharmaceuticals Oxytocin Injection Product Portfolio
  54. 6.9.5 JHP Pharmaceuticals Recent Developments
  55. 6.10 Grindex
  56. 6.10.1 Grindex Company Information
  57. 6.10.2 Grindex Business Overview
  58. 6.10.3 Grindex Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Grindex Oxytocin Injection Product Portfolio
  60. 6.10.5 Grindex Recent Developments
  61. 6.11 Bimeda
  62. 6.11.1 Bimeda Company Information
  63. 6.11.2 Bimeda Business Overview
  64. 6.11.3 Bimeda Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bimeda Oxytocin Injection Product Portfolio
  66. 6.11.5 Bimeda Recent Developments
  67. 6.12 Agrilab
  68. 6.12.1 Agrilab Company Information
  69. 6.12.2 Agrilab Business Overview
  70. 6.12.3 Agrilab Oxytocin Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Agrilab Oxytocin Injection Product Portfolio
  72. 6.12.5 Agrilab Recent Developments
7 North America by Country
  1. 7.1 North America Oxytocin Injection Sales by Country
  2. 7.1.1 North America Oxytocin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oxytocin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Oxytocin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oxytocin Injection Market Size by Country
  6. 7.2.1 North America Oxytocin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oxytocin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Oxytocin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oxytocin Injection Sales by Country
  2. 8.1.1 Europe Oxytocin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oxytocin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Oxytocin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oxytocin Injection Market Size by Country
  6. 8.2.1 Europe Oxytocin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oxytocin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oxytocin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oxytocin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Oxytocin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oxytocin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oxytocin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oxytocin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Oxytocin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oxytocin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oxytocin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oxytocin Injection Sales by Country
  2. 10.1.1 South America Oxytocin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oxytocin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Oxytocin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oxytocin Injection Market Size by Country
  6. 10.2.1 South America Oxytocin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oxytocin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Oxytocin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oxytocin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Oxytocin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oxytocin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oxytocin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oxytocin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Oxytocin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oxytocin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oxytocin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oxytocin Injection Value Chain Analysis
  2. 12.1.1 Oxytocin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oxytocin Injection Production Mode & Process
  7. 12.2 Oxytocin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oxytocin Injection Distributors
  10. 12.2.3 Oxytocin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst